Clin Hypertens.  2016 ;22(1):7. 10.1186/s40885-016-0042-0.

A review on prescribing patterns of antihypertensive drugs

• Jarari N
• Rao N
• Peela JR
• Ellafi KA
• Shakila S
• Said AR
• Nelapalli
• Min Y
• Tun KD
• Jamallulail SI
• Rawal AK
• Ramanujam
• Yedla RN
• Kandregula DK
• Argi A
• Peela LT

• KMID: 2380213
• DOI: http://doi.org/10.1186/s40885-016-0042-0

Abstract

Hypertension continues to be an important public health concern because of its associated morbidity, mortality and economic impact on the society. It is a significant risk factor for cardiovascular, cerebrovascular and renal complications. It has been estimated that by 2025, 1.56 billion individuals will have hypertension. The increasing prevalence of hypertension and the continually increasing expense of its treatment influence the prescribing patterns among physicians and compliance to the treatment by the patients. A number of national and international guidelines for the management of hypertension have been published. Since many years ago, diuretics were considered as the first-line drugs for treatment of hypertension therapy; however, the recent guidelines by the Joint National Commission (JNC8 guidelines) recommend both calcium channel blockers as well as angiotensin-converting enzyme inhibitors as first-line drugs, in addition to diuretics. Antihypertensive drug combinations are generally used for effective long-term management and to treat comorbid conditions. This review focuses on the antihypertensive medication utilization, their cost factors, adherence to treatment by patients, and physicians' adherence to guidelines in prescribing medications in different settings including Indian scenario. The antihypertensive medication prescribing pattern studies help in monitoring, evaluation and necessary modifications to the prescribing habits to achieve rational and cost-effective treatment. Additionally, periodic updating of recommended guidelines and innovative drug formulations, and prescription monitoring studies help in rational use of antihypertensive drugs, which can be tailored to suit the patients' requirements, including those in the developing countries.

MeSH Terms

Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Agents*
Calcium Channel Blockers
Chemistry, Pharmaceutical
Compliance
Developing Countries
Diuretics
Drug Combinations
Humans
Hypertension
Joints
Mortality
Prescriptions
Prevalence
Public Health
Risk Factors
Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Agents
Calcium Channel Blockers
Diuretics
Drug Combinations